Based on your PPT, here is the complete matter you should be able to speak on for each section during your presentation. This is structured slide-by-slide so you can talk confidently without just reading the slides.
Complete Presentation Matter - PharmD 6th Year Internship
SLIDE 1 - Title / Introduction
What to say:
"Good morning sir/ma'am. I am T. Lakshmi, PharmD 6th year, roll number 256220882030. This is my Biannual-1 internship assessment presentation covering my first 6 months of clinical internship from August 2025 to January 2026, under the guidance of Dr. P.D.S. Prakash sir, Assistant Professor, Department of Pharmacy Practice."
SLIDE 2 - Departments Covered
What to say:
"During the first half of my internship, I was posted in the following departments:
- August and September - ENT department
- October - Nursing ward
- November - General Medicine
- December - Paediatrics
- January - Orthopaedics
During this period I was involved in patient counselling, drug information queries, drug interaction documentation, and ADR reporting."
PART 1 - CASE PRESENTATION: ASTHMA
SLIDE 4 - Case Title
What to say:
"My first case presentation is on Asthma, from the General Medicine department. I will be presenting this using the SOAP format - Subjective, Objective, Assessment, and Planning."
SLIDE 5 - Subjective Analysis
What to say:
"The patient is a 55-year-old female who presented to the hospital with chief complaints of:
- Shortness of breath
- Fever
- Cold
- Chest pain
- Productive cough
Past Medical History: The patient is a known case of Asthma for 1 year and has been using an inhaler daily. She was also on Hydrocortisone 10mg.
Social History: She worked in chemical compounds for 22 years - this is clinically significant because occupational exposure to chemicals is a well-known trigger and risk factor for occupational asthma.
Allergy History: She is allergic to dust, strong smells, and cold climate for the past 7 years - these are classic asthma triggers."
SLIDE 6 - Objective Analysis
What to say:
"On examination, the following findings were noted:
Vitals:
- Temperature 100.2°F - elevated, indicating fever and possible infection
- Blood Pressure 110/70 mmHg - normal
- Pulse Rate 122 bpm - tachycardia, likely due to bronchodilator use, fever, or hypoxia
- SpO2 94% - this is below normal (normal >95%), indicating mild hypoxemia
- Respiratory Rate 20/minute - at upper limit of normal
Complete Blood Picture:
- Hemoglobin 10.6 g/dL - mild anemia
- WBC 14,900 cells/cumm - elevated, suggesting active infection
- Neutrophils 76% - neutrophilia, pointing towards bacterial infection
- Lymphocytes 19% - slightly low
- Eosinophils 1% - mildly elevated eosinophils are typically seen in allergic/asthma patients, but in this patient it is at lower end, possibly because she was already on steroids"
SLIDE 7 - Radiological + Assessment + Planning
What to say:
"Radiological Findings:
MRCT chest showed bilateral pleural thickening - this indicates chronic inflammatory changes consistent with her asthma history. Lymph nodes were noted, and degenerative changes of the dorsal spine in the form of osteophytes formation were observed - this explains why she was put on Pregabalin for neuropathic pain.
Assessment:
Based on the subjective and objective data, the patient was diagnosed with Asthma with bacterial superinfection.
Therapeutic Goals:
- Control bronchospasm and improve airway patency
- Treat the underlying bacterial infection
- Maintain adequate oxygenation (SpO2 >95%)
- Improve quality of life
- Reduce recurrence and hospitalization"
SLIDE 8 - Medication Chart (During Admission)
What to speak on (even if the slide has a table/image):
"During inpatient stay, the patient was likely on:
- IV/nebulized bronchodilators for acute symptom relief
- IV antibiotics for infection control
- Systemic corticosteroids for inflammation
- Oxygen supplementation for SpO2 correction
- Pantoprazole for gastric protection from steroids"
SLIDE 9 - Discharge Medications
What to say:
"At the time of discharge, the patient was prescribed the following medications:
1. Tab. Pantoprazole 40mg OD oral
- This is a Proton Pump Inhibitor
- Given for gastric protection because corticosteroids like Hydrocortisone can cause gastric irritation and ulcers with long-term use
2. Neb. Duolin (Salbutamol + Ipratropium) TID via nebulizer
- This is a combination bronchodilator
- Given as the primary maintenance therapy for asthma symptoms
- I will explain this in detail in my Drug Information Query slide
3. Tab. Pregabalin 500mg OD oral
- Pregabalin is an anticonvulsant used for neuropathic pain
- In this patient, it is given for pain associated with osteophyte formation in the dorsal spine seen on CT scan
4. Tab. Ceftriaxone 250mg OD oral
- Third generation cephalosporin antibiotic
- Given because the patient had elevated WBC and neutrophilia, indicating a bacterial respiratory infection superimposed on asthma
- Patient is advised to follow up in 7 days"
DRUG INFORMATION QUERY - DUOLIN (Asthma)
What to say:
"The drug information query for this case was: What is the recommended dose, route, and rationale for using Duolin in a patient with Asthma?"
What is Duolin?
"Duolin is a combination bronchodilator containing two active components:
- Salbutamol (Levosalbutamol) - a short acting beta-2 adrenergic agonist (SABA)
- Ipratropium bromide - a short acting muscarinic antagonist (SAMA)"
Mechanism of Action:
"Salbutamol acts on beta-2 adrenergic receptors present on bronchial smooth muscle. On binding, it activates adenyl cyclase, which converts ATP to cAMP. Increased cAMP activates Protein Kinase A, which phosphorylates myosin light chain kinase, preventing smooth muscle contraction. This results in bronchodilation and relief of bronchospasm.
Ipratropium bromide competitively blocks M3 muscarinic receptors in the bronchial smooth muscle and submucosal glands. This prevents acetylcholine from causing bronchoconstriction and reduces excessive mucus secretion."
Why combination?
"When both drugs are used together:
- They act through two completely different pathways (adrenergic and cholinergic)
- Faster onset with longer duration of action
- More effective than either drug alone
- Lower doses of each drug can be used, reducing the risk of side effects"
Dose:
"Via nebulizer: Salbutamol 2.5mg + Ipratropium 500mcg in 2.5-3ml normal saline, 3 times daily"
ADRs:
"From Salbutamol: Tremors, palpitations, tachycardia, hypokalemia
From Ipratropium: Dry mouth, urinary retention, constipation, blurred vision
Combined: Paradoxical bronchospasm (rare but dangerous)"
DRUG INTERACTION DOCUMENTATION - ASTHMA
What to say:
"For this case, I documented two major drug-drug interactions involving Tramadol as the objective drug.
Interaction 1: Pregabalin + Tramadol - Major Interaction
Both Pregabalin and Tramadol are CNS depressants. When used together, they produce additive CNS and respiratory depression. This can lead to excessive sedation, respiratory failure, and in severe cases, coma.
Management: Start with the lowest effective dose of both drugs, monitor respiratory rate, SpO2, and level of consciousness. Avoid other CNS depressants like alcohol. Educate patient to report any difficulty in breathing or confusion immediately.
Interaction 2: Tramadol + Levosalbutamol - Major Interaction
Tramadol affects serotonin and norepinephrine pathways in the brain. Levosalbutamol is a beta-2 agonist and acts as a stimulant. When combined, this can disturb the autonomic nervous system balance, leading to tremors, anxiety, palpitations, and risk of arrhythmias.
Management: Monitor heart rate and blood pressure regularly. Avoid caffeine and other stimulants. Reassure the patient if symptoms are mild and self-limiting."
PATIENT COUNSELLING - ASTHMA
What to say:
"Patient counselling was done for Mrs. XYZ, a 55-year-old female admitted for asthma.
Disease counselling:
- Explained the nature of asthma - a chronic inflammatory airway disease with reversible bronchospasm
- Explained her triggers: dust, strong smells, cold air, chemical exposure
- Advised to avoid workplace chemical exposure
Medication counselling:
- Taught correct nebulizer technique - explained that the mask must cover nose and mouth, breathe slowly and deeply, session lasts 10-15 minutes
- Advised not to stop inhaler/medications on their own even if feeling better
- Explained the importance of Pregabalin for back pain - take at bedtime due to sedation
- Ceftriaxone course must be completed
Lifestyle counselling:
- Maintain healthy weight, regular mild exercise
- Balanced diet with fruits, vegetables
- Stay current with flu and pneumonia vaccinations
- Keep windows closed when pollen counts are high
- Avoid cold air exposure - use a scarf over mouth in cold weather
- Do not smoke; avoid passive smoking
- Regular follow-up every 7 days initially"
ADR REPORT 1 - VANCOMYCIN (ENT - CSOM, 4-year-old child)
What to say:
"This ADR report is from the ENT department. The patient is a 4-year-old male child diagnosed with Right Ear Chronic Suppurative Otitis Media (CSOM).
CSOM is defined as a chronic infection of the middle ear with persistent discharge through a perforated tympanic membrane for more than 2 weeks.
Drugs prescribed:
- Syrup Levorid (Levocetirizine) 2.5ml oral HS - antihistamine for allergic component
- Syrup Ambroxol 3ml oral BD - mucolytic to thin mucus secretions
- Syrup Doxycycline 3.5ml oral BD - antibiotic
- Syrup Augmentin (Amoxicillin-Clavulanate) 4ml oral BD - broad spectrum antibiotic
- Inj. Vancomycin 575mg IV TID - glycopeptide antibiotic for resistant organisms
Observed ADR:
On Day 2 of therapy, the patient developed:
- Generalized itching and fever
- Facial swelling
- Wheezing
Suspected Drug: Inj. Vancomycin - most likely cause
What this reaction represents:
This reaction is consistent with Red Man Syndrome, which is a non-immunological (non-IgE mediated) infusion reaction caused by rapid IV infusion of Vancomycin. Rapid infusion causes direct mast cell degranulation and histamine release, leading to flushing, erythema, itching, and wheezing.
However, the presence of facial swelling and wheezing also raises concern for anaphylaxis - an IgE-mediated Type I hypersensitivity reaction, which is more serious.
Causality Assessment using Naranjo Scale:
- The reaction occurred after Vancomycin administration
- Improved after stopping the drug
- Known adverse effect of Vancomycin
- Naranjo Score: Probable reaction (score 5-8)
WHO-UMC Causality: Probable
Action taken:
- Vancomycin was stopped immediately
- Clindamycin was started as an alternative
- Patient was monitored and symptoms resolved within 24 hours
Why Clindamycin?
- Clindamycin inhibits the 50S ribosomal subunit of bacteria, preventing protein synthesis - bacteriostatic
- Active against Gram-positive organisms and anaerobes
- Suitable alternative for ear infections with Vancomycin hypersensitivity
Important clinical note:
Doxycycline prescribed in this case is contraindicated in children below 8 years of age because it binds to calcium in developing bone and teeth, causing permanent yellow-brown tooth discoloration and inhibiting bone growth. This should have been flagged during medication review."
CASE PRESENTATION 2 - PARAOVARIAN CYST (Gynaecology)
What to say:
Subjective:
"The second case is from the Gynaecology department. The patient is a 20-year-old nulligravida (woman who has never been pregnant) who presented with pain in the right lower abdomen for 5 days - dragging type, radiating to the left side, not relieving on rest.
She is a known case of PCOS (Polycystic Ovarian Syndrome) for 1 year.
Social history: Mixed diet, adequate sleep, no addictions."
Objective:
"Vitals were within normal limits - BP 110/80, PR 86 bpm, Temp 98°F, RR 20.
Important lab findings:
- TSH: 7.8 mIU/L - significantly elevated (normal 0.4-4.0 mIU/L) - indicating primary hypothyroidism
- T3 and T4 were low - confirming hypothyroidism
Radiological findings:
USG abdomen and pelvis showed:
- Mild hepatomegaly
- Polycystic pattern of left ovary - consistent with PCOS
- Anechoic cystic lesion on right ovary - this is the paraovarian cyst
Surgery performed: Laparoscopic paraovarian cystectomy"
Assessment:
"Patient diagnosed with Nulligravida with Abnormal Uterine Bleeding (AUB) with Right Paraovarian Cyst, with co-existing PCOS and Hypothyroidism.
Paraovarian cyst is a benign cyst arising from remnants of the Wolffian (mesonephric) duct or mesothelial cells, located in the broad ligament, separate from the ovary.
AUB in this context is likely caused by the combination of PCOS (anovulatory cycles) and hypothyroidism (which causes menorrhagia by affecting coagulation and ovarian function)."
DRUG INFORMATION - CIPROFLOXACIN (INJ. CIFRAN)
What to say:
"The drug information query for this case was regarding Inj. Cifran (Ciprofloxacin), which was prescribed post-operatively for prevention of surgical site infection.
What is Ciprofloxacin?
Ciprofloxacin is a second-generation fluoroquinolone antibiotic with broad-spectrum bactericidal activity.
Mechanism of Action:
Ciprofloxacin inhibits two bacterial enzymes:
- DNA gyrase (Topoisomerase II) - required for DNA supercoiling and compaction during replication
- Topoisomerase IV - required for separating interlinked daughter chromosomes after replication
By inhibiting both enzymes, Ciprofloxacin prevents bacterial DNA replication, transcription, and repair, ultimately leading to bacterial cell death. This is why it is bactericidal.
Spectrum of activity:
Primarily active against Gram-negative organisms (E. coli, Klebsiella, Pseudomonas), some Gram-positive organisms, and atypical organisms. Useful for intra-abdominal infections, UTIs, respiratory infections.
Dose:
- Mild to moderate: 250-500mg oral every 12 hours
- Severe or complicated: 500-750mg oral every 12 hours
- IV: 200-400mg every 12 hours
- Duration: 3-14 days depending on infection
ADRs:
- GI: Nausea, vomiting, diarrhea (most common)
- Musculoskeletal: Tendinitis and tendon rupture (especially Achilles tendon) - Black Box Warning
- CNS: Headache, dizziness, seizures
- QT prolongation - risk of arrhythmia
- Photosensitivity
- Contraindicated in children (damages developing cartilage) and pregnancy
Important interaction:
Ciprofloxacin significantly increases Theophylline levels when given together - very relevant in asthma patients."
DRUG INTERACTION - GYNAECOLOGY (Alprazolam + Cetirizine)
What to say:
"This drug interaction was documented in a 19-year-old female patient admitted for post-menopausal bleeding in the Gynaecology department.
Drugs: Tab. Alprax (Alprazolam) + Tab. Cetirizine
Interaction Type: Moderate drug-drug interaction
Mechanism:
Alprazolam is a benzodiazepine that enhances the activity of GABA-A receptors in the brain. GABA-A is a ligand-gated chloride ion channel. When Alprazolam binds to its allosteric site (between α and γ subunits), it increases the frequency of chloride channel opening, leading to hyperpolarization of the neuron, producing sedation and anxiolysis.
Cetirizine is a second-generation H1 antihistamine. Although second-generation antihistamines are considered less sedating than first-generation, Cetirizine still has mild CNS penetration and mild sedative properties.
When both drugs are given together, they produce additive CNS depression, leading to increased drowsiness, dizziness, impaired concentration, and slowed reaction time.
Clinical Management:
- Advise patient not to drive or operate machinery
- Monitor for excessive sedation
- Avoid alcohol while on both drugs
- Consider dose reduction if sedation is severe"
ADR REPORT 2 - CEFTRIAXONE (General Surgery - Head Injury RTA)
What to say:
"This ADR report is from the General Surgery department. The patient is a 41-year-old male admitted for head injury secondary to Road Traffic Accident (RTA).
Drugs prescribed:
- Inj. Monocef (Ceftriaxone) 1gm IV BD - antibiotic for infection prevention
- Inj. Dynapar (Diclofenac) 75mg IV BD - NSAID for pain
- Inj. Pan (Pantoprazole) 40mg IV OD - gastroprotection
- Inj. Zofer (Ondansetron) 4mg IV SOS - antiemetic
- Tab. Metrogyl (Metronidazole) 400mg oral TID - anaerobic coverage
- Tab. Limcee (Vitamin C) 1 tab oral OD - wound healing
- Tab. Zerodol-P (Aceclofenac + Paracetamol) oral BD - pain management
Observed ADR:
On Day 3 of therapy, patient developed severe diarrhea and fever.
Suspected Drug: Inj. Monocef (Ceftriaxone) - causing antibiotic-associated diarrhea
Mechanism:
Ceftriaxone is a third-generation cephalosporin that is excreted not only through urine but also significantly through bile into the intestine. This disrupts the normal gut microbiota, allowing opportunistic organisms like Clostridioides difficile (C. diff) to overgrow. C. diff produces toxins A and B that cause mucosal damage, leading to severe diarrhea and fever - known as Clostridioides difficile-associated diarrhea (CDAD) or pseudomembranous colitis.
Causality: Probable (Naranjo Scale)
Action Taken:
- Assessed severity and frequency of diarrhea
- Encouraged oral fluid intake to prevent dehydration
- Reviewed need for Ceftriaxone - consider switching to an alternative antibiotic
- Monitored electrolyte balance (risk of hypokalemia and hyponatremia with severe diarrhea)
What antibiotic should replace Ceftriaxone?
For C. diff infection:
- Stop the causative antibiotic
- Start oral Metronidazole (already on IV Metrogyl in this case) or oral Vancomycin for severe cases"
LIFESTYLE MODIFICATION - GYNAECOLOGY CASE
What to say:
"Lifestyle modification counselling was done for the Gynaecology patient post-surgery:
- Stress management: yoga, meditation, deep breathing - important because stress worsens hormonal imbalance and PCOS
- Weight management: Obesity contributes to PCOS recurrence by increasing estrogen levels through peripheral aromatization
- Post-surgery diet: Avoid carbonated drinks, beans, and fried foods - these cause bloating and abdominal discomfort after laparoscopic surgery
- Fiber-rich diet - important also because this patient has hypothyroidism which causes constipation
- Take thyroid medications (thyroxine) regularly and on empty stomach - critical because TSH was 7.8
- Regular follow-up for USG to monitor for cyst recurrence"
HOW TO OPEN AND CLOSE YOUR PRESENTATION
Opening:
"Good morning to the respected faculty, preceptor, and fellow students. I, T. Lakshmi, PharmD 6th year, am here to present my Biannual-1 Internship Assessment. During this 6-month internship, I had the opportunity to apply clinical pharmacy skills in real patient care settings across 5 departments. I will be presenting one case from General Medicine on Asthma, and one case from Gynaecology on Paraovarian Cyst, along with drug information queries, drug interaction documentation, ADR reports, and patient counselling."
Closing:
"In conclusion, this internship has given me hands-on experience in patient care, identifying drug-related problems, documenting adverse drug reactions, and providing drug information. I identified clinically significant drug interactions in both cases and conducted ADR reporting using the Naranjo causality assessment scale. I thank Dr. P.D.S. Prakash sir for his guidance throughout this period. I am now open to questions."
KEY TERMS to Define if Asked
| Term | Definition |
|---|
| SOAP | Subjective, Objective, Assessment, Plan - clinical documentation format |
| Naranjo Scale | 10-question tool to assess causality of ADR (score: Definite ≥9, Probable 5-8, Possible 1-4) |
| WHO-UMC | World Health Organization - Uppsala Monitoring Centre causality categories |
| Type A ADR | Predictable, dose-related, extension of pharmacological effect (e.g., diarrhea with antibiotics) |
| Type B ADR | Unpredictable, not dose-related, immune-mediated (e.g., anaphylaxis with Vancomycin) |
| Red Man Syndrome | Non-IgE pseudo-allergic reaction to rapid Vancomycin infusion |
| CDAD | Clostridioides difficile-associated diarrhea - from antibiotic disruption of gut flora |
| SABA | Short-Acting Beta Agonist (Salbutamol) |
| SAMA | Short-Acting Muscarinic Antagonist (Ipratropium) |
| Nulligravida | A woman who has never been pregnant |
| PCOS | Polycystic Ovarian Syndrome |
| AUB | Abnormal Uterine Bleeding |
You have all the matter you need. Practice speaking each slide out loud at least once tonight - aim for about 1.5 to 2 minutes per slide. Good luck tomorrow!